{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T05:11:17Z","timestamp":1697951477082},"reference-count":6,"publisher":"Oxford University Press (OUP)","issue":"671","license":[{"start":{"date-parts":[[1981,9,1]],"date-time":"1981-09-01T00:00:00Z","timestamp":368150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1981,9,1]]},"abstract":"<jats:title>Summary<\/jats:title>\n               <jats:p>The authors describe a diabetic patient on spironolactone who, following a minor surgical procedure, developed ketoacidosis and life-threatening hyperkalaemia.<\/jats:p>","DOI":"10.1136\/pgmj.57.671.573","type":"journal-article","created":{"date-parts":[[2008,12,29]],"date-time":"2008-12-29T20:43:59Z","timestamp":1230583439000},"page":"573-574","source":"Crossref","is-referenced-by-count":1,"title":["Spironolactone and diabetic ketoacidosis"],"prefix":"10.1093","volume":"57","author":[{"given":"A G","family":"Jariwalla","sequence":"first","affiliation":[{"name":"Department of Medicine, University Hospital of Wales , Heath Park, Cardiff CF4 4XW"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Lever","sequence":"additional","affiliation":[{"name":"Department of Medicine, University Hospital of Wales , Heath Park, Cardiff CF4 4XW"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C R","family":"Jones","sequence":"additional","affiliation":[{"name":"Department of Medicine, University Hospital of Wales , Heath Park, Cardiff CF4 4XW"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Hall","sequence":"additional","affiliation":[{"name":"Department of Medicine, University Hospital of Wales , Heath Park, Cardiff CF4 4XW"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[1981,9,1]]},"reference":[{"key":"ref_1","author":"GUNDERSON, K.; BRADLEY, R.F.; MARBLE, A.","year":"1954","unstructured":"GUNDERSON, K., BRADLEY, R.F. & MARBLE, A. (1954)"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1056\/NEJM195404012501302","article-title":"Serum phosphorus and potassium levels after intravenous administration of glucose","volume":"250","unstructured":"Serum phosphorus and potassium levels after intravenous administration of glucose. New England Journal of Medicine, 250, 547.","journal-title":"New England Journal of Medicine"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1001\/archneur.1966.00470130078008","article-title":"Fatal hyperkalemic paralysis associated with spironolactone. Observation on a patient with severe renal disease and refractory edema","volume":"15","author":"HERMAN, E.; RADO, J.","year":"1966","unstructured":"HERMAN, E. & RADO, J. (1966) Fatal hyperkalemic paralysis associated with spironolactone. Observation on a patient with severe renal disease and refractory edema. Archives of Neurology. Chicago, 15, 74.","journal-title":"Archives of Neurology. Chicago"},{"key":"ref_4","first-page":"158","article-title":"Spironolactone","volume":"19","author":"KARIM, A.; ZAGARELLA, A.; HRIBAR, J.; DOOLEY, M.","year":"1976","unstructured":"KARIM, A., ZAGARELLA, A., HRIBAR, J. & DOOLEY, M. (1976) Spironolactone. I. Disposition and metabolism. Clinical Pharmacology and Therapeutics, 19, 158.","journal-title":"I. Disposition and metabolism. Clinical Pharmacology and Therapeutics"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/0026-0495(70)90118-6","article-title":"Possible predisposition of diabetic patients to hyperkalemia following administration of potassium-retaining diuretic, amiloride (MK870)","volume":"19","author":"MCNAY, J.L.; ORAN, E.","year":"1970","unstructured":"MCNAY, J.L. & ORAN, E. (1970) Possible predisposition of diabetic patients to hyperkalemia following administration of potassium-retaining diuretic, amiloride (MK870). Metabolism, 19, 58.","journal-title":"Metabolism"},{"key":"ref_6","first-page":"376","article-title":"The electrocardiogram and potassium metabolism","volume":"23","author":"BUCHERNE, V.A.N.; P, F.S.","year":"1957","unstructured":"VAN BUCHERNE, F.S.P. (1957) The electrocardiogram and potassium metabolism, American Journal of Education, 23, 376.","journal-title":"American Journal of Education"}],"container-title":["Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/57\/671\/573\/49290869\/postgradmedj-57-573.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/57\/671\/573\/49290869\/postgradmedj-57-573.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T13:24:48Z","timestamp":1681997088000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pmj\/article\/57\/671\/573\/7050386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1981,9,1]]},"references-count":6,"journal-issue":{"issue":"671","published-online":{"date-parts":[[1981,9,1]]},"published-print":{"date-parts":[[1981,9,1]]}},"URL":"https:\/\/doi.org\/10.1136\/pgmj.57.671.573","relation":{},"ISSN":["0032-5473","1469-0756"],"issn-type":[{"value":"0032-5473","type":"print"},{"value":"1469-0756","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[1981,9]]},"published":{"date-parts":[[1981,9,1]]}}}